|
Market Closed -
NYSE
16:00:00 2026-09-03 EDT
|
5-day change | 1st Jan Change | ||
| 1.670 USD | +5.70% |
|
-1.01% | -66.40% |
| 08-21 | Kairos Pharma to Conduct 1-for-7 Reverse Stock Split | MT |
| 08-12 | Kairos Pharma, Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| Market Cap | 5.65M 4.86M 4.56M 4.18M 7.79M 534M 7.86M 54M 21.03M 273M 21.23M 20.77M 880M | P/E 2026 * |
-0.72x | P/E 2027 * | -0.47x |
|---|---|---|---|---|---|
| Enterprise Value | 5.65M 4.86M 4.56M 4.18M 7.79M 534M 7.86M 54M 21.03M 273M 21.23M 20.77M 880M | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
66.39% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| KAPA | Delayed | |
CBOE
| KAPA | Real-time |
| 1 day | +5.70% | ||
| 1 week | -1.01% | ||
| Current month | -0.60% | ||
| 1 month | -23.05% | ||
| 3 months | -48.41% | ||
| 6 months | -61.78% | ||
| Current year | -66.40% |
| 1 week | 1.51 |  | 1.85 |
| 1 month | 1.51 | | 2.84 |
| Current year | 1.51 | | 7.28 |
| 1 year | 1.51 | | 14.77 |
| 3 years | 1.51 | | 28 |
| 5 years | 1.51 | | 28 |
| 10 years | 1.51 | | 28 |
| Manager | Title | Age | Since |
|---|---|---|---|
John Yu
CEO | Chief Executive Officer | 61 | 2013-06-16 |
Doug Samuelson
DFI | Director of Finance/CFO | 66 | 2018-12-31 |
| Chief Tech/Sci/R&D Officer | 66 | - |
| Director | Title | Age | Since |
|---|---|---|---|
John Yu
CHM | Chairman | 61 | 2013-06-16 |
Hyun Bae
BRD | Director/Board Member | 56 | 2020-09-08 |
Han-Soo Keyoung
BRD | Director/Board Member | 51 | 2024-09-10 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/8/25 | Free | Chief Financial Officer | 152,672 | 0.7360% | ||
| 10/8/25 | Free | Chief Executive Officer | 190,840 | 0.9200% | ||
| 10/8/25 | Free | Director | 19,084 | 0.0920% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +5.70% | -1.01% | -83.66% | - | 5.65M | |
| +0.41% | -2.07% | +41.26% | +95.40% | 69.02B | |
| -0.94% | +0.96% | +43.14% | +90.31% | 66.32B | |
| +0.04% | +4.36% | -11.72% | +459.54% | 27.66B | |
| -0.90% | -7.65% | +2.45% | -15.50% | 25.84B | |
| -3.00% | -2.90% | +39.40% | +9.41% | 26.54B | |
| -0.14% | +1.76% | +25.73% | -17.61% | 20.4B | |
| +3.45% | -13.46% | +222.69% | +389.50% | 17.63B | |
| -1.49% | -4.88% | -0.41% | +530.26% | 15.15B | |
| +1.03% | +7.00% | +59.98% | +160.03% | 14.65B | |
| Average | +0.42% | -1.34% | +33.89% | +189.04% | 28.32B | |
| Weighted average by Cap. | -0.30% | -0.83% | +41.73% | +148.37% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -7.94M -6.83M -6.41M -5.87M -10.95M -751M -11.04M -75.86M -29.54M -384M -29.82M -29.17M -1.24B | -14.16M -12.18M -11.43M -10.46M -19.53M -1.34B -19.68M -135M -52.68M -684M -53.18M -52.02M -2.2B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-03 | US$1.670 | +5.70% | 47,901 |
| 26-09-02 | US$1.580 | -4.24% | 105,402 |
| 26-09-01 | US$1.650 | -1.79% | 77,601 |
| 26-08-31 | US$1.680 | +1.22% | 53,527 |
| 26-08-28 | US$1.660 | -1.62% | 31,979 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- KAPA Stock
Select your edition
All financial news and data tailored to specific country editions
